233 related articles for article (PubMed ID: 34997294)
1. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.
Visser D; Verfaillie SCJ; Wolters EE; Coomans EM; Timmers T; Tuncel H; Boellaard R; Golla SSV; Windhorst AD; Scheltens P; van der Flier WM; van Berckel BNM; Ossenkoppele R
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1951-1963. PubMed ID: 34997294
[TBL] [Abstract][Full Text] [Related]
2. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease.
Visser D; Wolters EE; Verfaillie SCJ; Coomans EM; Timmers T; Tuncel H; Reimand J; Boellaard R; Windhorst AD; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3165-3175. PubMed ID: 32462397
[TBL] [Abstract][Full Text] [Related]
3. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study.
Wolters EE; van de Beek M; Ossenkoppele R; Golla SSV; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Barkhof F; Boellaard R; Windhorst AD; van der Flier WM; Scheltens P; Lemstra AW; van Berckel BNM
Neuroimage Clin; 2020; 28():102504. PubMed ID: 33395993
[TBL] [Abstract][Full Text] [Related]
4. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease.
Tanner JA; Iaccarino L; Edwards L; Asken BM; Gorno-Tempini ML; Kramer JH; Pham J; Perry DC; Possin K; Malpetti M; Mellinger T; Miller BL; Miller Z; Mundada NS; Rosen HJ; Soleimani-Meigooni DN; Strom A; La Joie R; Rabinovici GD
Brain; 2022 Dec; 145(12):4489-4505. PubMed ID: 35762829
[TBL] [Abstract][Full Text] [Related]
5. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
6. Regional [
Wolters EE; Ossenkoppele R; Verfaillie SCJ; Coomans EM; Timmers T; Visser D; Tuncel H; Golla SSV; Windhorst AD; Boellaard R; van der Flier WM; Teunissen CE; Scheltens P; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2866-2878. PubMed ID: 32291510
[TBL] [Abstract][Full Text] [Related]
7. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
Cho H; Mundada NS; Apostolova LG; Carrillo MC; Shankar R; Amuiri AN; Zeltzer E; Windon CC; Soleimani-Meigooni DN; Tanner JA; Heath CL; Lesman-Segev OH; Aisen P; Eloyan A; Lee HS; Hammers DB; Kirby K; Dage JL; Fagan A; Foroud T; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Nudelman K; Toga A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez M; Musiek E; Onyike CU; Riddle M; Rogalski EJ; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Koeppe R; Iaccarino L; Dickerson BC; La Joie R; Rabinovici GD;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S98-S114. PubMed ID: 37690109
[TBL] [Abstract][Full Text] [Related]
8. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal [
Wolters EE; Ossenkoppele R; Golla SS; Verfaillie SC; Timmers T; Visser D; Tuncel H; Coomans EM; Windhorst AD; Scheltens P; van der Flier WM; Boellaard R; van Berckel BN
Neuroimage Clin; 2020; 25():102113. PubMed ID: 31835238
[TBL] [Abstract][Full Text] [Related]
10. Genetically identical twins show comparable tau PET load and spatial distribution.
Coomans EM; Tomassen J; Ossenkoppele R; Golla SSV; den Hollander M; Collij LE; Weltings E; van der Landen SM; Wolters EE; Windhorst AD; Barkhof F; de Geus EJC; Scheltens P; Visser PJ; van Berckel BNM; den Braber A
Brain; 2022 Oct; 145(10):3571-3581. PubMed ID: 35022652
[TBL] [Abstract][Full Text] [Related]
11. Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
Devous MD; Fleisher AS; Pontecorvo MJ; Lu M; Siderowf A; Navitsky M; Kennedy I; Southekal S; Harris TS; Mintun MA
J Alzheimers Dis; 2021; 80(3):1091-1104. PubMed ID: 33682705
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging study.
Visser D; Verfaillie SCJ; Bosch I; Brouwer I; Tuncel H; Coomans EM; Rikken RM; Mastenbroek SE; Golla SSV; Barkhof F; van de Giessen E; van Berckel BNM; van der Flier WM; Ossenkoppele R
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2409-2419. PubMed ID: 36976303
[TBL] [Abstract][Full Text] [Related]
13. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
14. Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease.
Kang JM; Shin JH; Kim WR; Seo S; Seo H; Lee SY; Park KH; Na DL; Okamura N; Seong JK; Noh Y
J Alzheimers Dis; 2023; 94(3):1233-1246. PubMed ID: 37393505
[TBL] [Abstract][Full Text] [Related]
15. Connectivity and Patterns of Regional Cerebral Blood Flow, Cerebral Glucose Uptake, and Aβ-Amyloid Deposition in Alzheimer's Disease (Early and Late-Onset) Compared to Normal Ageing.
Germán F; Andres D; Leandro U; Nicolás N; Graciela L; Yanina B; Patricio C; Adriana Q; Cecilia B; Ismael C; Ismael C; de León MP; Valeria C; Feuerstein V; Sergio D; Ricardo A; Henry E; Silvia V
Curr Alzheimer Res; 2021; 18(8):646-655. PubMed ID: 34784866
[TBL] [Abstract][Full Text] [Related]
16. In vivo tau pathology is associated with synaptic loss and altered synaptic function.
Coomans EM; Schoonhoven DN; Tuncel H; Verfaillie SCJ; Wolters EE; Boellaard R; Ossenkoppele R; den Braber A; Scheper W; Schober P; Sweeney SP; Ryan JM; Schuit RC; Windhorst AD; Barkhof F; Scheltens P; Golla SSV; Hillebrand A; Gouw AA; van Berckel BNM
Alzheimers Res Ther; 2021 Feb; 13(1):35. PubMed ID: 33546722
[TBL] [Abstract][Full Text] [Related]
17. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
18. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
19. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
[TBL] [Abstract][Full Text] [Related]
20. Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals.
Ebenau JL; Visser D; Verfaillie SCJ; Timmers T; van Leeuwenstijn MSSA; Kate MT; Windhorst AD; Barkhof F; Scheltens P; Prins ND; Boellaard R; van der Flier WM; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):410-422. PubMed ID: 36071221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
